Latest news with #TheInsightPartners
Business Upturn
a day ago
- Business
- Business Upturn
Frozen Food Market Size to expected to reach US$ 444.22 Billion by 2031, Rising Demand for Convenience Food Drives Growth
By GlobeNewswire Published on June 2, 2025, 16:44 IST US & Canada, June 02, 2025 (GLOBE NEWSWIRE) — According to a new comprehensive report from The Insight Partners, the frozen food market is witnessing significant growth owing to the growing consumption of convenience food. The report runs an in-depth analysis of market trends, key players, and future opportunities. The frozen food market comprises an array of platforms and services that are expected to determine the market strength in the coming years. To explore the valuable insights in the Frozen Food Market report, you can easily download a sample PDF of the report – Overview of Report Findings Market Growth: The frozen food market size is expected to reach US$ 444.22 billion by 2031 from US$ 295.39 billion in 2024; it is likely to register a CAGR of 6.0% during the forecast period. The rising demand for convenience food owing to the hectic lifestyle is driving the growth of the frozen food market. Additionally, rapid urbanization, rising per capita income, and changing retail scenario are some of the key factors driving the frozen food market growth. The increasing penetration of smartphones and the internet, easy access to emerging technologies, rising purchasing power, and convenience provided by online retail platforms of shopping from anywhere at any time are among the key factors bolstering e-commerce. This factor contributes to the growth of the frozen food market by eliminating the dependency on offline retail stores. Growing Consumption of Convenience Food: Over the past few years, the lifestyles of people across the world have evolved dramatically. Due to hectic work schedules, people's dependency on products that save time and effort has increased. The surge in the consumption of high-quality convenience food is one of the biggest trends in the food industry. Convenience food, such as frozen snacks, frozen meals, cold cuts, and ready-to-eat products, allows consumers to save time and effort associated with ingredient shopping, meal preparation and cooking, consumption, and post-meal activities. The development and popularity of these food items are ascribed to many social changes; the most notable of these are the increasing number of smaller households and the rising millennial population across the world. Due to hectic work schedules, millennials prefer to be efficient with their time, rather than spending it on tedious tasks. Thus, they are more likely to spend their money on convenience food. These factors are significantly boosting the demand for convenience food among consumers, eventually boosting the growth of the frozen food market. In recent decades, women's participation in workforce in different countries has increased tremendously. A significant rise in the employment of women boosts the popularity of convenience food, such as frozen food, among working-class populations. Thus, the rising demand for convenience food is supporting the growth of the frozen food market. Burgeoning Popularity of Plant-Based Frozen Products: Veganism has gained significant momentum in recent years. Consumers are highly inclined toward plant-based products as they perceive them to be healthier than conventional products. Additionally, increasing awareness regarding animal protection and environmental sustainability is adding to the popularity of these food products. The proliferation of the veganism wave across the world is highly influencing innovations in the frozen food market. Registrations for the Veganuary Campaign have increased dramatically over the past few years. The flourishing trend of veganism has encouraged manufacturers of frozen food to launch plant-based products. Thus, the growing inclination toward plant-based food, with the rocketing popularity of veganism, is expected to bring new trends in the frozen food market during the forecast period. Geographical Insights: In 2024, Europe led the market with a substantial revenue share, followed by North America and Asia Pacific. Asia Pacific is expected to register the highest CAGR during the forecast period. For Detailed Frozen Food Market Insights, Visit: Market Segmentation Based on type, the frozen food market is segmented into frozen desserts; frozen meat, poultry, and seafood; frozen bakery; frozen snacks & appetizers; frozen ready meals; and others. The frozen meat, poultry, and seafood segment held the largest share of the market in 2024. In terms of distribution channel, the market is segmented into supermarkets and hypermarkets, convenience stores, online retail, and others. The supermarkets and hypermarkets segment held the largest share of the market in 2024. The frozen food market is segmented into five major regions: North America, Europe, APAC, Middle East & Africa, and South & Central America. Stay Updated on The Latest Frozen Food Market Trends: Competitive Strategy and Development Key Players: Conagra Brands Inc, General Mills Inc, Pepperidge Farm Inc, Bonduelle Group, McCain Foods Ltd, Bellisio Foods Inc, Tyson Foods Inc, Kellogg's Co, Nestlé SA, and The Kraft Heinz Co. are among the major companies operating in the frozen food market. Trending Topics: Rise of Plant-Based and Vegan Products, Premium and Gourmet Frozen Meals, Convenient Breakfast Solutions, Snackable and Miniature Portions, and Sustainable and Eco-Friendly Packaging. Global Headlines on Frozen Food HyFun Foods and Woolworths collaborated to expand the premiumization of frozen foods into mainstream food aisles. Wyman's has launched three new frozen products, marking its fourth new product launch in four years, including Protein Blends for smoothies, Fruit First Waffles, and Fruit and Peanut Butter Poppers. MBC acquired Nardone Brothers Frozen Pizza Company, providing a third processing plant in Pennsylvania and immediate access to dayparts beyond breakfast. Lakeside Foods acquired Smith Frozen Foods, which is expected to finalize the acquisition by early next week. Benford Capital Partners acquired Turri's Italian Foods Inc, a frozen Italian pasta and rice manufacturer, marking its 16th investment in the food industry and its sixth platform investment in the Chicago-based firm. Purchase Premium Copy of Global Frozen Food Market Size and Growth Report (2021-2031) at: Conclusion The rising demand for convenience food owing to hectic work schedules is driving the frozen food market growth. Also, the ever-growing food industry with product innovation and enhanced technology is propelling the market. With rising demand for healthy and plant-based food among consumers, frozen food manufacturers are focusing on this trend in their product innovation. Moreover, rising retail sales of frozen foods, including breads, meat, snacks, and appetizers, are projected to drive the market during the forecast period. The report from The Insight Partners provides several stakeholders—including frozen food providers and frozen food manufacturers—with valuable insights into navigating this evolving market landscape and unlocking new opportunities. Talk to Us Directly: Trending Related Reports: About Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact Us: If you have any queries about this report or if you would like further information, please contact us: Contact Person: Ankit Mathur E-mail: [email protected] Phone: +1-646-491-9876 Home – Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Yahoo
5 days ago
- Business
- Yahoo
Monoclonal Antibody Therapeutics Market Size to Reach USD 619.60 Billion by 2031, Driven by Production of mAB-Based Drugs to Treat Several Diseases and Innovative Product Launches Propels
According to a new comprehensive report from The Insight Partners, the global monoclonal antibody therapeutics market is witnessing substantial growth with the production of mAB-based drugs to treat several diseases and innovative product launches. US & Canada, May 30, 2025 (GLOBE NEWSWIRE) -- The report carries an in-depth analysis of market trends, key players, and future opportunities. The monoclonal antibody therapeutics market study focuses on an array of products and technologies that are expected to fuel the demand in the coming years. The monoclonal antibody therapeutics market is booming with advancements in technology, the increase in chronic diseases, and the demand for personalized medicine. Recombinant DNA and hybridoma technology have enabled monoclonal antibody therapies to be more effective and specific. These therapies have been put to use in treating cancer, autoimmune diseases, and infectious diseases. North America is the leading investing region and will benefit more than Europe and the United Kingdom, mainly due to high healthcare spending and more advanced healthcare infrastructure. Asia Pacific is also likely to be the space with the fastest growth potential as healthcare infrastructure improves, healthcare awareness and spending accelerate, and investment in biopharmaceuticals and related research grows. The increased adoption of biosimilars and strategic alliances among pharmaceutical companies is set to give the FDA more tools, tactics, and plans for correcting declines that limit the accessibility and affordability of monoclonal antibody therapies. In summary, the monoclonal antibody therapeutics market will experience explosive growth as technology advances, rates of diseases increase, and personalized medicine adoption continues to expand. To explore the valuable insights in the Monoclonal Antibody Therapeutics Market report, you can easily download a sample PDF of the report - Overview of Report Findings Market Growth: The monoclonal antibody therapeutics market is expected to reach US$ 619.60 billion by 2031 from US$ 249.14 billion in 2024; it is anticipated to record a CAGR of 13.9% during the forecast period. Monoclonal antibody therapeutics are artificially manufactured antibodies that can imitate, restore, or enhance the immune system's response to harmful agents. These biologics are characterized by their high specificity as they are made to bind to identifiable antigens on cancer cells, viruses, and other disease-causing agents. Monoclonal antibodies are administered for treating various diseases and conditions (including oncology, autoimmune diseases, and infectious diseases). Monoclonal antibody therapeutics allow for specificity and reduced adverse effects, unlike traditional therapies. The therapeutic market for monoclonal antibodies continues to grow significantly due to the increased incidence of chronic diseases, breakthroughs in biotechnology, and the growth of personalized medicines. The success of monoclonal antibodies as a treatment for COVID-19 opened the door to investing in monetizing their therapeutic potential, leading to significant research and investment. Trends also suggest that the market for monoclonal antibodies will remain on a growth trajectory due to supportive regulatory policies, an increase in approval rates for novel monoclonal antibody products, and strong acceptance in emerging economies. Projections for the monoclonal antibody market continue to indicate it will reach considerable market figures in the coming years, indicating that monoclonal antibody therapeutics should be a priority in the biopharmaceutical sector. Increasing Incidence of Chronic and Autoimmune Diseases: The increasing incidence of both chronic and autoimmune diseases is a considerable force propelling the growth of the monoclonal antibody (mAb) therapeutics market. Although mAb therapeutics remain a small segment of the overall therapeutics market, they treat a number of chronic and autoimmune diseases, such as rheumatoid arthritis, multiple sclerosis, Crohn's Disease, and various types of cancers. Unlike traditional therapies, mAb therapeutics are highly specific in targeting disease-associated antigens and provide better responses with higher efficacy and fewer side effects. As awareness grows among healthcare providers and patients regarding biologic treatments, the demand for mAb therapeutics propels. Along with recognized demand, biotechnology and genetic engineering have made significant progress to allow developments in creating and producing better, lower-cost monoclonal antibodies, creating considerable excitement in the healthcare market. Pharmaceuticals are responding with enormous investments in research and development, accelerating their (new mAb therapeutics) product pipelines, ending with more mAb therapeutics on the market. Next-Generation Antibody Technologies: Next-generation antibody technologies are transforming the mAb therapeutics market with better efficacy, safety, and specificity. Novel approaches, including bispecific antibodies, antibody-drug conjugates (ADCs), and engineered Fc regions, are allowing for more precise classes of therapeutics for difficult-to-treat diseases such as cancers, autoimmune diseases, and infectious diseases. These novel approaches allow for better pharmacokinetics and the capability to engage multiple antigens or immune pathways simultaneously. In addition, antibody humanization and fully human antibody libraries minimize potential immunogenicity risks in patients, improving overall outcomes. Artificial intelligence and high-throughput screening are also speeding up the mAb discovery and optimizing processes, allowing pharmaceutical companies to shorten timeframes for development. The monoclonal antibody business will begin to skyrocket as biopharmaceutical companies embrace novel antibody technologies and change the monoclonal antibody landscape toward demand for more efficient, effective, and tailored therapeutics. As a result, next-generation antibody platforms represent a major opportunity for transformation and development of the future of targeted therapeutics. Geographical Insights: In 2024, North America led the monoclonal antibody therapeutics market with a substantial revenue share, followed by Europe and Asia Pacific. Further, Asia Pacific is expected to register the highest CAGR during the forecast period. Get Updated Sample on Monoclonal Antibody Therapeutics Market Report: Market Segmentation Based on product, the market is segmented into recombinant mABs, antibody-drug conjugates, bispecific and multispecific mABs, biosimilars, and others. The recombinant mABs segment held the largest share of the market in 2024. By application, the market is categorized into cancer, autoimmune diseases, rheumatoid arthritis, psoriasis, ulcerative colitis, and others. The autoimmune diseases segment accounted for the largest share of the market in 2024. In terms of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment dominated the market in 2024. The monoclonal antibody therapeutics market is segmented into five major regions: North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America. Talk to Us Directly: Competitive Strategy and Development Key Players: GlaxoSmithKline, Bayer AG, Amgen, Novartis, AbbVie, Bristol-Myers Squibb, Janssen Pharmaceutical, Merck KgaA, and AstraZeneca are among the major companies operating in the market. Trending Topics: Radiolabeled monoclonal antibodies (radioimmunotherapy), AI-engineered antibody design & in silico screening, sustainable manufacturing of mAbs, and microbiome-modulating monoclonal antibodies. Global Headlines on Monoclonal Antibody Therapeutics Salipro Biotech and Icosagen launch antibody discovery collaboration. Antibody therapeutics approved or in regulatory review in the EU or US. LifeArc and Cleveland Clinic join forces to develop new monoclonal antibody therapeutics for patients with high unmet medical needs. AbbVie and OSE Immunotherapeutics announce a partnership to develop a novel monoclonal antibody for the treatment of chronic inflammation. Conclusion The report from The Insight Partners lists several stakeholders—including pharmaceutical companies, biotechnology firms, contract research organizations (CROs), and healthcare providers—along with valuable insights to navigate this evolving market landscape and unlock new opportunities Premium Copy of Global Monoclonal Antibody Therapeutics Market Size and Growth Report (2020-2031) at: Related Reports: Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact Us: If you have any queries about this report or if you would like further information, please contact us: Contact Person: Ankit Mathur E-mail: Phone: +1-646-491-9876Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 days ago
- Business
- Yahoo
Continence Care Market Size to Surpass USD 9.54 Billion by 2031 With 5.6% CAGR, Surging Prevalence of Chronic Diseases Propels the Demand
The report from The Insight Partners lists several stakeholders—including healthcare providers, medical device companies, distributors and retailers, and payers and insurance providers—along with valuable insights to navigate this evolving market landscape and unlock new opportunities successfully. US & Canada, May 30, 2025 (GLOBE NEWSWIRE) -- According to a new comprehensive report from The Insight Partners, the global continence care market is witnessing substantial growth with the surging prevalence of chronic diseases and government initiatives to increase awareness regarding urological diseases. The report carries an in-depth analysis of market trends, key players, and future opportunities. The continence care market study focuses on an array of products and technologies that are expected to fuel the demand in the coming explore the valuable insights in the Continence Care Market report, you can easily download a sample PDF of the report – of Report Findings 1. Market Growth: The continence care market is expected to reach US$ 9.54 billion by 2031 from US$ 6.51 billion in 2024; it is anticipated to record a CAGR of 5.6% during the forecast period. Continence care comprises urinary and fecal incontinence products and services that are designed to help people get a better life in their conditions. Among the things that the area covers are incontinence pads, adult diapers, urinary catheters, and skin care products. The demand for continence care is surging due to the aging population, the increasing prevalence of diabetes and obesity, and the emerging importance of controlling incontinence. Technological advancements have propelled the introduction of biodegradable absorbent products and sensor-embedded smart urinary catheters, which are capable of meeting the needs of patients and care providers differently. The market growth is fueled by surging investments in the healthcare sector, augmentation of the technology, and patients' comfort and dignity expectations. The emerging economies of the Asia-Pacific region are witnessing high growth alongside the increased accessibility of the healthcare system, greater awareness, and increased disposable income. 2. Increasing Prevalence of Incontinence Disorders: Rising incidence rates of incontinence-related disorders propel the growth of the continence care market. With the aging population, the prevalence of obesity, diabetes, neurological and urinary disorders, and fecal incontinence are increasing. The increased awareness about incontinence and the availability of successful treatments has reduced the stigma, improving treatment access. Healthcare providers and institutions are spending on high-caliber continence care products to provide better outcomes for patients and reduce infections and skin breakdown. As a result, manufacturers and healthcare professionals are developing new comfort, absorbency, and discretion features in their products. 3. Expanding Emerging Markets: The continence care market in emerging nations is growing due to rising healthcare awareness, a surging middle-class population, and increasing investments in healthcare infrastructure. The demand for adult diapers, pads, and catheters is increasing as life expectancy is prolonged and populations mature. The urbanization process and rising income are the additional factors influencing the consumer shift from generic, lower-quality continence care products to branded and higher-quality ones. Also, the authorities and non-governmental organizations (NGOs) in these regions are concentrating on efforts to improve healthcare access and hygiene standards in the population. The relatively unexploited status of these markets offers global manufacturers the chance to move into new markets due to the access they provide. It also allows for the customization of products to suit cultural and economic conditions. The use of e-commerce and digital health platforms reduces the difficulty in accessing products and offers more knowledge to the consumer. Thus, these forces make the developing world a suitable investment area for continence care. 4. Geographical Insights: In 2024, North America led the continence care market with a substantial revenue share, followed by Europe and Asia Pacific. Further, Asia Pacific is expected to register the highest CAGR during the forecast period. Get Updated Sample pages of Continence Care Market Report: Market Segmentation By product, the market is categorized into catheters, urine bags, protective incontinence garments, and others. The catheter segment accounted for the largest share of the market in 2024. Based on type, the market is categorized into fecal incontinence care and urinary incontinence care. The urinary incontinence care segment accounted for a larger share of the market in 2024. Per end user, the market is segmented into hospitals and specialty clinics, home care, and others. The hospitals and specialty clinics segment held the largest share of the market in 2024. The continence care market is segmented into five major regions: North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America. Competitive Strategy and Development Key Players: Hollister Incorporated, Coloplast, Alcare Co. Ltd., B. Braun SE, Convatec Inc., Cardinal Health, Boston Scientific Corporation, Essity, and Paul Hartmann AG are major companies operating in the market. Trending Topics: Electrical stimulation devices for incontinence management, wearable and smart continence management systems, eco-friendly and sustainable product innovations, and digital health platforms and patient engagement. Global Headlines on Continence Care Convatec's Continence Care launches me+ Companion app digital health app. New project aims to improve continence care services affected by COVID-19. FDA grants 510(k) clearance to Yō Bladder Support for SUI. Purchase Premium Copy of Global Continence Care Market Size and Growth Report (2025-2031) at: Conclusion The continence care market growth is driven by an expanding global population, rising incidence of diabetes and neurological disorders, and increasing awareness regarding incontinence management. New product designs, including better absorbency, comfort, and discreetness, are driving consumer expectations for more dignified and user-friendly options in home care settings or institutions. Emerging markets, the expansion of healthcare infrastructure, and the rise of home healthcare services have played a role in the continued penetration of healthcare economies. The continued investments in research and development, along with partnerships between manufacturers and hospitals or other providers, positively impact the quality of life for those suffering from to Us Directly: Related Reports: Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact Us: If you have any queries about this report or if you would like further information, please contact us: Contact Person: Ankit Mathur E-mail: Phone: +1-646-491-9876Sign in to access your portfolio
Yahoo
5 days ago
- Business
- Yahoo
Continence Care Market Size to Surpass USD 9.54 Billion by 2031 With 5.6% CAGR, Surging Prevalence of Chronic Diseases Propels the Demand
The report from The Insight Partners lists several stakeholders—including healthcare providers, medical device companies, distributors and retailers, and payers and insurance providers—along with valuable insights to navigate this evolving market landscape and unlock new opportunities successfully. US & Canada, May 30, 2025 (GLOBE NEWSWIRE) -- According to a new comprehensive report from The Insight Partners, the global continence care market is witnessing substantial growth with the surging prevalence of chronic diseases and government initiatives to increase awareness regarding urological diseases. The report carries an in-depth analysis of market trends, key players, and future opportunities. The continence care market study focuses on an array of products and technologies that are expected to fuel the demand in the coming explore the valuable insights in the Continence Care Market report, you can easily download a sample PDF of the report – of Report Findings 1. Market Growth: The continence care market is expected to reach US$ 9.54 billion by 2031 from US$ 6.51 billion in 2024; it is anticipated to record a CAGR of 5.6% during the forecast period. Continence care comprises urinary and fecal incontinence products and services that are designed to help people get a better life in their conditions. Among the things that the area covers are incontinence pads, adult diapers, urinary catheters, and skin care products. The demand for continence care is surging due to the aging population, the increasing prevalence of diabetes and obesity, and the emerging importance of controlling incontinence. Technological advancements have propelled the introduction of biodegradable absorbent products and sensor-embedded smart urinary catheters, which are capable of meeting the needs of patients and care providers differently. The market growth is fueled by surging investments in the healthcare sector, augmentation of the technology, and patients' comfort and dignity expectations. The emerging economies of the Asia-Pacific region are witnessing high growth alongside the increased accessibility of the healthcare system, greater awareness, and increased disposable income. 2. Increasing Prevalence of Incontinence Disorders: Rising incidence rates of incontinence-related disorders propel the growth of the continence care market. With the aging population, the prevalence of obesity, diabetes, neurological and urinary disorders, and fecal incontinence are increasing. The increased awareness about incontinence and the availability of successful treatments has reduced the stigma, improving treatment access. Healthcare providers and institutions are spending on high-caliber continence care products to provide better outcomes for patients and reduce infections and skin breakdown. As a result, manufacturers and healthcare professionals are developing new comfort, absorbency, and discretion features in their products. 3. Expanding Emerging Markets: The continence care market in emerging nations is growing due to rising healthcare awareness, a surging middle-class population, and increasing investments in healthcare infrastructure. The demand for adult diapers, pads, and catheters is increasing as life expectancy is prolonged and populations mature. The urbanization process and rising income are the additional factors influencing the consumer shift from generic, lower-quality continence care products to branded and higher-quality ones. Also, the authorities and non-governmental organizations (NGOs) in these regions are concentrating on efforts to improve healthcare access and hygiene standards in the population. The relatively unexploited status of these markets offers global manufacturers the chance to move into new markets due to the access they provide. It also allows for the customization of products to suit cultural and economic conditions. The use of e-commerce and digital health platforms reduces the difficulty in accessing products and offers more knowledge to the consumer. Thus, these forces make the developing world a suitable investment area for continence care. 4. Geographical Insights: In 2024, North America led the continence care market with a substantial revenue share, followed by Europe and Asia Pacific. Further, Asia Pacific is expected to register the highest CAGR during the forecast period. Get Updated Sample pages of Continence Care Market Report: Market Segmentation By product, the market is categorized into catheters, urine bags, protective incontinence garments, and others. The catheter segment accounted for the largest share of the market in 2024. Based on type, the market is categorized into fecal incontinence care and urinary incontinence care. The urinary incontinence care segment accounted for a larger share of the market in 2024. Per end user, the market is segmented into hospitals and specialty clinics, home care, and others. The hospitals and specialty clinics segment held the largest share of the market in 2024. The continence care market is segmented into five major regions: North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America. Competitive Strategy and Development Key Players: Hollister Incorporated, Coloplast, Alcare Co. Ltd., B. Braun SE, Convatec Inc., Cardinal Health, Boston Scientific Corporation, Essity, and Paul Hartmann AG are major companies operating in the market. Trending Topics: Electrical stimulation devices for incontinence management, wearable and smart continence management systems, eco-friendly and sustainable product innovations, and digital health platforms and patient engagement. Global Headlines on Continence Care Convatec's Continence Care launches me+ Companion app digital health app. New project aims to improve continence care services affected by COVID-19. FDA grants 510(k) clearance to Yō Bladder Support for SUI. Purchase Premium Copy of Global Continence Care Market Size and Growth Report (2025-2031) at: Conclusion The continence care market growth is driven by an expanding global population, rising incidence of diabetes and neurological disorders, and increasing awareness regarding incontinence management. New product designs, including better absorbency, comfort, and discreetness, are driving consumer expectations for more dignified and user-friendly options in home care settings or institutions. Emerging markets, the expansion of healthcare infrastructure, and the rise of home healthcare services have played a role in the continued penetration of healthcare economies. The continued investments in research and development, along with partnerships between manufacturers and hospitals or other providers, positively impact the quality of life for those suffering from to Us Directly: Related Reports: Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact Us: If you have any queries about this report or if you would like further information, please contact us: Contact Person: Ankit Mathur E-mail: Phone: +1-646-491-9876Sign in to access your portfolio
Yahoo
6 days ago
- Business
- Yahoo
Sternal Closure Systems Market Size to Grow USD 6.32 Billion by 2031 with 6.1% CAGR, Advancements in Surgical Techniques and Rising Incidence of Cardiovascular Diseases Fuel
The global sternal closure systems market growth is driven by the increasing prevalence of cardiovascular diseases, advancements in surgical techniques, and a rising geriatric population. US & Canada, May 28, 2025 (GLOBE NEWSWIRE) -- According to a new comprehensive report from The Insight Partners, the sternal closure systems market is witnessing significant growth owing to the advancements in surgical techniques and the rising incidence of cardiovascular diseases (CVDs). The sternal closure systems market analysis focuses on advancements such as rigid plate fixation systems and bioabsorbable sternal closure devices. These advancements are expected to accelerate the market growth in the coming years. The report runs an in-depth analysis of market trends, key players, and future opportunities. Titanium-based systems dominate due to their biocompatibility and strength. Key players include Johnson & Johnson (DePuy Synthes), Zimmer Biomet, KLS Martin Group, B. Braun Melsungen AG, and Stryker Corporation. To explore the valuable insights in the sternal closure systems Market report, you can easily download a sample PDF of the report - Overview of Report Findings 1. Market Growth: The sternal closure systems market value is expected to reach US$ 6.32 billion by 2031 from US$ 4.22 billion in 2024; the market is anticipated to register a CAGR of 6.1% during 2025–2031. The market growth is attributed to the advancements in surgical techniques, the rising incidence of CVDs, and technological innovations in closure devices. 2. Advancements in Surgical Techniques: Conventional open-heart surgeries involving full sternotomy are progressively being supplemented or substituted by cutting-edge methods such as minimally invasive surgery (MIS), robotically assisted procedures, and enhanced recovery after surgery (ERAS) protocols. These technologies necessitate sternal closure systems to offer greater stability, support smaller incisions, and enable quicker healing. Rigid plate fixation systems, bioabsorbable implants, and individually designed implants are now available to address these changing surgical needs. These technologies provide better biomechanical stability compared to traditional wire cerclage, minimizing the chances of complications such as sternal dehiscence, non-union, and postoperative infections. Sternal closure systems that facilitate quicker patient mobilization and shorter hospital stays are being preferred by surgeons nowadays, which is consistent with contemporary healthcare priorities of efficiency and value-based care. Furthermore, the movement toward patient-specific procedures, such as 3D-printed implants and hybrid surgical techniques, has driven the demand for flexible and precision-driven solutions in closure. With the emergence of sophisticated surgical procedures and a surge in minimally invasive techniques, the demand for sophisticated, dependable closure systems rises even higher. Such a progression in surgical technique continues to drive innovation within the sternal closure systems market, ensuring ongoing worldwide growth. 3. Rising Incidence of Cardiovascular Diseases (CVDs): The increasing prevalence of CVDs is the key driver for the sternal closure systems market. Heart disease is the major cause of death globally, and as populations age, become less active, and consume poor diets, coronary artery disease, heart valve abnormalities, and congenital heart disease get more prominent. These ailments frequently necessitate surgical procedures such as coronary artery bypass grafting (CABG), heart valve replacement, or corrective surgeries—most of which involve a median sternotomy, in which the sternum is opened to reach the heart. The surgical procedure requires successful postoperative sternal closure to facilitate successful healing, reduce complications such as sternal dehiscence or infection, and enable quick patient recovery. With the rate of cardiac surgery increasing each year, particularly in high-burden areas such as North America, Europe, and developing economies in Asia Pacific, the demand for sophisticated sternal closure systems such as rigid fixation plates, bioabsorbable implants, and patient-specific solutions has increased dramatically. In addition, hospitals are shifting focus toward outcome-driven care, which makes durable, safe, and patient-comfortable closure methods the need of the hour. This trend, driven by the increasing CVD burden, is likely to continue driving innovation and uptake in the global sternal closure systems market. 4. Geographical Insights: In 2024, North America led the market with a substantial revenue share, followed by Europe and Asia Pacific. Asia Pacific is expected to register the highest CAGR during the forecast period. Market Segmentation Based on product, the sternal closure systems market is bifurcated into closure devices and bone cement. The closure devices segment held a larger market share in 2024. By procedure, the sternal closure systems market is segmented into median sternotomy, hemisternotomy, bilateral thoracosternotomy, and others. The median sternotomy segment dominated the market in 2024. In terms of material, the sternal closure systems market is segmented into titanium, polyether ether ketone, stainless steel, and others. The titanium segment dominated the market in 2024. The sternal closure systems market is segmented into five major regions: North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. Stay Updated on The Latest sternal closure systems Market Trends: Competitive Strategy and Development Key players: Johnson and Johnson Services, Inc.; A&E Medical Corporation; B. Braun Melsungen AG; DePuy Synthes; Acute Innovations LLC; KLS Martin Group; IDEAR S.R.L.; Zimmer Biomet Holdings, Inc.; ABYRX, Inc.; and Kinamed Incorporated are among the major companies operating in the sternal closure systems market. Trending topics: Advancements in Closure Devices, Emergence of Bioadhesive Materials, Integration of Robotic and Minimally Invasive Systems, Development of Smart and Biodegradable Systems. Headlines on Sternal Closure Systems DePuy Synthes, The Orthopaedics Company of Johnson & Johnson and part of Johnson & Johnson MedTech, announced the launch of the MatrixSTERNUM Fixation System, a plate and screw fixation system to help stabilize and secure the front part of the chest wall after open-heart surgery and chest surgery. Able Medical Devices announced the launch of Valkyrie Looped Sternotomy Sutures. The stainless-steel looped wire sutures are used to close a patient's chest after open heart surgery. Zimmer Biomet has acquired A&E Medical and its complete portfolio of sternal closure devices – including sternal sutures, cable systems, and rigid fixation – along with a range of single-use complementary temporary pacing wire and surgical punch products. Purchase Premium Copy of Global sternal closure systems Market Size and Growth Report (2020-2030) at: Conclusion The sternal closure systems market is witnessing high growth due to the rising incidence of cardiovascular diseases and technological advancements in surgery. The introduction of rigid plate fixation, bioabsorbable technology, and patient-specific 3D-printed implants has improved outcomes through greater stability and lower complications. Migration toward minimally invasive procedures and improved infection control drives the need for advanced closure solutions. Growth in awareness among medical professionals and positive reimbursement policies are also driving market uptake. Therefore, the market is expected to continue to propel as technology improves and the demand for efficient, safe sternal closure techniques increases worldwide. The report from The Insight Partners provides several stakeholders—including closure devices and bone cement manufacturers—with valuable insights to successfully navigate this evolving market landscape and unlock new opportunities. Talk to Us Directly: Trending Related Reports: About Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact Us: If you have any queries about this report or if you would like further information, please contact us: Contact Person: Ankit Mathur E-mail: Phone: +1-646-491-9876 Home -
